CureVac BV (CVAC) has fallen Thursday morning, with the stock declining -2.30% in pre-market trading to 2.98.
CVAC's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 98 out of 146 industries, the stock ranks higher than 66% of stocks.
CureVac BV has fallen 11.08% over the past month, closing at $3.38 on February 22. During this period of time, the stock fell as low as $2.94 and as high as $3.66. CVAC has an average analyst recommendation of Buy. The company has an average price target of $11.00.
CVAC has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on CVAC!
CureVac BV has a Long-Term Technical rank of 7. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 93% of the market scoring higher. In the Biotechnology industry which is number 70 by this metric, CVAC ranks better than 70% of stocks.
